Sunday 29 Dec, 2024 02:41 AM
Site map | Locate Us | Login
   CARE Ratings affirms Shalimar Paints' 'BBB-' rating with 'negative' outlook    Deep Industries board OKs proposal to raise funds up to Rs 350-crore via QIP route    Mahindra EPC Irrigation bags Rs 3.40-cr order for micro irrigation systems    CAMS board OKs to invest Rs 8-cr in CAMS Financial Information Services    Reliance Inds acquires Karkinos Healthcare to expand health services portfolio    Newgen Software Tech bags Rs 24-cr order from Aye Finance    CARE Ratings upgrades long-term rating of Eureka Forbes to 'AA-' with 'stable' outlook    Bright Outdoor gains on bagging bulk advertising contract worth Rs 60 crore    Odigma Consultancy Solutions Ltd leads losers in 'B' group    Volumes soar at Finolex Industries Ltd counter    Fortis Healthcare rises on appointing Leo Puri as chairman    Capital Goods shares slide    Oil and Gas stocks edge lower    Metal shares fall    Dish TV India Ltd slips for fifth straight session 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Reliance Inds acquires Karkinos Healthcare to expand health services portfolio
28-Dec-24   11:46 Hrs IST

The acquisition was made by subscribing to 1 crore equity shares worth Rs 10 crore and allotting 36.50 crore optionally fully convertible debentures (OFCDs) for Rs 365 crore in Karkinos.

As part of the acquisition, Karkinos has cancelled 30,075 outstanding equity shares held by the previous shareholders in accordance with the approved resolution plan. With the completion of the equity share allotment to RSBVL and the cancellation of existing shares, Karkinos is now a step-down wholly-owned subsidiary of Reliance Industries.

Karkinos was incorporated in India on 24 July 2020, and is in the business of providing technology-driven, innovative solutions for the early detection, diagnosis, and management of cancer. The company reported a turnover of Rs 21.91 crore for FY 2023, compared to Rs 0.92 crore in FY 2022 and Rs 0.004 crore in FY 2021. The acquisition of Karkinos will help expand the health services business portfolio of the Reliance group.

The resolution plan for Karkinos was approved by the Hon'ble National Company Law Tribunal (NCLT), Mumbai Bench, and no additional governmental or regulatory approvals were needed for the transaction.

The company clarified that the investment does not fall under a related party transaction, and neither the company's promoters nor its group companies have any interest in the deal.

Earlier, on 10, December 2024, Reliance announced that the NCLT had approved the resolution plan submitted by RSBVL for Karkinos under the Corporate Insolvency Resolution Process of the Insolvency and Bankruptcy Code, 2016.

Reliance Industries (RIL) is India's largest private sector company. Its activities span hydrocarbon exploration and production, petroleum refining and marketing, petrochemicals, renewables (solar and hydrogen), retail and digital services.

RIL had reported a 3.6% fall in consolidated net profit to Rs 19,101 crore in Q2 FY25 from Rs 19,820 crore in Q2 FY24. Gross revenue rose by 0.8% YoY to Rs 258,027 crore in the second quarter.

The scrip had rose 0.36% to end at Rs 1,220.95 on the BSE on Friday.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 37822659
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd